These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33493091)

  • 21. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.
    Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J
    Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
    Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
    PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
    Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
    JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
    Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
    Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice.
    Urushiyama H; Terasaki Y; Nagasaka S; Kokuho N; Endo Y; Terasaki M; Kunugi S; Makita K; Isago H; Hosoki K; Souma K; Ishii T; Matsuzaki H; Hiraishi Y; Mikami Y; Noguchi S; Tamiya H; Mitani A; Yamauchi Y; Shimizu A; Nagase T
    J Cell Mol Med; 2019 May; 23(5):3563-3571. PubMed ID: 30873733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis.
    Cheng MH; Kuo HF; Chang CY; Chang JC; Liu IF; Hsieh CC; Hsu CH; Li CY; Wang SC; Chen YH; Chang CR; Lee TY; Liu YR; Huang CY; Wu SH; Liu WL; Liu PL
    Biomed Pharmacother; 2024 May; 174():116572. PubMed ID: 38626519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
    Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis.
    Guillotin D; Taylor AR; Platé M; Mercer PF; Edwards LM; Haggart R; Miele G; McAnulty RJ; Maher TM; Hynds RE; Jamal-Hanjani M; Marshall RP; Fisher AJ; Blanchard AD; Chambers RC
    Thorax; 2021 Jan; 76(1):73-82. PubMed ID: 33214245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
    J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
    Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
    Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
    Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
    PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predisposition for disrepair in the aged lung.
    Sueblinvong V; Neujahr DC; Mills ST; Roser-Page S; Ritzenthaler JD; Guidot D; Rojas M; Roman J
    Am J Med Sci; 2012 Jul; 344(1):41-51. PubMed ID: 22173045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.